Clinton A. Lewis, Jr.
Executive Vice President & President of International Operations, Zoetis Inc.
Clinton A. Lewis, 51, currently serves as executive vice president and president of international operations at Zoetis Inc., a NYSE-listed global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines that was spun off by Pfizer in 2013. Prior to being named to his current role in May 2015, he served as president of U.S. operations at Zoetis from October 2012 to May 2015 and at Pfizer Animal Health from 2007 to October 2012. He joined Pfizer in 1988, and held positions of increasing responsibility across various commercial operations dedicated to human health prior to joining the animal health organization. He formerly served as chairman of the board for the Animal Health Institute (AHI), an industry trade association in the U.S., and currently serves as treasurer for the International Federation for Animal Health (IFAH), the industry trade association in Europe. He earned a bachelor’s degree in biology from Fairfield University and a master of business administration in marketing from Fairleigh Dickinson University. Director since November 4, 2017.